Loading clinical trials...
Loading clinical trials...
An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-400945 Fumarate Administered Orally to Patients With Advanced Cancer
Conditions
Interventions
CFI-400945
Locations
2
United States
UCLA Medical Center
Santa Monica, California, United States
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Start Date
March 1, 2014
Primary Completion Date
July 1, 2021
Completion Date
July 22, 2021
Last Updated
January 17, 2024
NCT04657068
NCT04900818
NCT05004116
NCT06440005
NCT07246954
NCT06242470
Lead Sponsor
University Health Network, Toronto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions